U.S. stock night trading opens with fluctuations: Opendoor Tech rises 10.09% in night trading; IREN rises 5.20% in night trading

U.S. Stock Night Market Opening Movements Opendoor Tech rose 10.09% in the night market. Based on recent key news: On September 24, Opendoor Technologies' stock surged in after-hours trading as Jane Street Group disclosed holding a 5.9% stake in the company. This news boosted market confidence and drove the stock price up. Data source: Benzinga. On September 23, a strong new home sales report released by the U.S. Census Bureau and the Department of Housing and Urban Development propelled Opendoor Technologies' stock price higher. The strong housing demand backdrop is favorable for the company's sales volume increase. Data source: Benzinga. On September 22, investment firm Access Industries sold a large amount of Opendoor stock, leading to stock price fluctuations. Nevertheless, Opendoor's stock price has still risen nearly 80% this month. Data source: LSEG. The real estate market demand is strong, and stock prices are highly volatile. IREN rose 5.20% in the night market. According to recent key news: On September 22, IREN announced that its AI cloud GPU capacity has doubled to 23,000 units and set ambitious revenue targets. This expansion drove the stock price up by 10.3%. Data source: company announcement. On September 24, Arete Research rated IREN stock as a buy and set a target price of $78, further boosting the stock price. Data source: analyst report. On September 24, Bernstein raised IREN's target price from $20 to $75 and maintained an "outperform" rating based on expected expansion of its AI cloud business. Data source: analyst report. The expansion of the AI cloud business drives the stock price up. Top Gainers in the U.S. Stock Night Market PepGen rose 123.68% in the night market. Based on recent important news: On September 24, PepGen announced that its PGN-EDODM1 achieved an average splice correction rate of 53.7% in patients with type 1 malnutrition, with all patients showing splice improvement. This positive clinical data drove the stock price up. Data source: company announcement. On September 24, PepGen announced plans for an initial public offering, with proceeds to be used for research and clinical trials. This news sparked optimistic expectations in the market regarding the company's future development, driving the stock price up. Data source: Reuters. On September 24, Guggenheim reiterated its buy rating on PepGen and maintained a target price of $6. This analyst rating supported market confidence in the stock. Data source: Guggenheim. The biotechnology sector has been active recently Stitch Fix rose 10.28% in after-hours trading. Based on recent key news: On September 24, Stitch Fix reported better-than-expected fourth-quarter earnings, with revenue and earnings per share exceeding analyst expectations. The company also issued a fiscal year 2026 guidance that was above expectations, driving the stock price up. On September 24, the company announced that net revenue per active customer increased by 3% year-over-year to $549, despite a 7.9% decline in the number of active customers. This data indicates increased customer spending, boosting market confidence. On September 24, Stitch Fix emphasized its ongoing efforts to improve customer experience and product offerings, and plans to continue leveraging artificial intelligence and stylist services to support future growth. These positive prospects further propelled the stock price upward. The online services industry performed well overall, with macroeconomic data supporting growth